Return to content in this issue

 

Reduced Prostaglandin D2 Production by Airway Fibroblasts in Nonsteroidal Anti-inflammatory Drug- Exacerbated Airway Disease

Roca-Ferrer J1,2, Machado-Carvalho L3,4, Picado C1,2

1Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
2Centro de Investigaciones en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
3Department of Biology and Environment, School of Life Sciences and Environment, University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
4Center for Research and Technology of Agro-Environmental and Biological Sciences (CITAB-UTAD), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal

J Investig Allergol Clin Immunol 2025; Vol. 35(4)
doi: 10.18176/jiaci.1062

Key words: Asthma, Aspirin, N-ERD, Prostaglandin E2, Prostaglandin D2